First-trimester messenger RNA (mRNA)-based COVID-19 vaccine exposure does not increase major congenital malformation (MCM) risk, according to a recent study published in JAMA Network Open.1
Data has indicated significantly increased severe…
Blog
-
Full art Mythical Pokémon from Mega Evolution steadily dropping in price
Marshadow, the Gloomdweller Pokémon, is one of the rarest finds from generation VII. It’s not possible to obtain it in the digital games without downloading it via an exclusive event. In the Pokémon TCG, this shadowy lurker emerged from…
Continue Reading
-
HIV updates put comorbidities first — ART on cruise control
PARIS, October 17, 2025 — The European AIDS Clinical Society (EACS) has shifted the focus of its guidelines toward managing comorbidities and the health needs of an aging HIV population, while making only incremental changes to first-line…
Continue Reading
-
For Today’s Young Content Creators, Chaos Reigns on TikTok
Polished and perfect are out, and candid and messy are in. At least that’s what it appears consumers on social media are drawn to when connecting with creators in 2025.
Some influencers are pivoting away from meticulously curated profile…
Continue Reading
-
Google Updates AI Studio with Advanced Features for Developers
Google has unveiled a series of enhancements to its AI Studio platform, aiming to empower developers with greater precision and efficiency in building artificial intelligence applications. The updates, detailed in a recent post on the
Continue Reading
-
ESMO 2025: Perioperative Enfortumab Vedotin (EV) plus Pembrolizumab (Pembro) in Participants with Muscle-Invasive Bladder Cancer (MIBC) Who Are Cisplatin-Ineligible: The Phase 3 KEYNOTE-905 Study – UroToday
- ESMO 2025: Perioperative Enfortumab Vedotin (EV) plus Pembrolizumab (Pembro) in Participants with Muscle-Invasive Bladder Cancer (MIBC) Who Are Cisplatin-Ineligible: The Phase 3 KEYNOTE-905 Study UroToday
- Pfizer and Astellas announce positive results from phase 3ev-303 clinical trial for Padcev in combination with Keytruda TradingView
- Enfortumab Vedotin Plus Pembro Cuts Risk of Disease Progression, Death 60% for Patients With MIBC Who Can’t Have Chemo With Bladder Removal The American Journal of Managed Care® (AJMC®)
- ESMO25: Padcev, Keytruda regimen given before, after surgery shines in bladder cancer FirstWord Pharma
- KEYNOTE-905: EV/pembrolizumab emerges as new option for cisplatin-ineligible MIBC Urology Times
Continue Reading
-
Socialite Lady Annabel Goldsmith remembered as ‘simply irreplaceable’ after death | UK News
Lady Annabel Goldsmith, the socialite who gave her name to a famous Mayfair nightclub, has died aged 91.
Her son Ben Goldsmith, an environmentalist and financier, described her as “quite simply irreplaceable” and said her life had…
Continue Reading
-
Nanoscale machines are made from DNA and ‘reboot’ with heat
Tiny devices built from DNA can already compute, sense, and move. The sticking point has been power, because most designs run once and stall when their fuel runs out.
A new study shows that a short pulse of heat can reset and recharge these DNA…
Continue Reading
-
Miniature tools were South China’s ancient strategy for survival
Small stone tools in South China reflect a history of adaptation. A new analysis shows that people repeatedly chose small, portable designs as climates shifted and groups moved.
The scale is large for archaeology. A team examined more than 12,000…
Continue Reading
-
Physicists found strong hints of “tipping point” in nuclear matter
Physicists at a New York collider have tightened the search for a long-predicted tipping point in nuclear matter. The new result marks a sharp feature at 19.6 billion electron volts per nucleon pair that could signal where the strong force…
Continue Reading